_:n1fccaf7abac04d4cb0615b5b71f6d124xb5
<http://schema.org/guideline>
"The dose of Austedo is determined individuals for each patient based on reduction of tardive dyskinesia and tolerability. When first prescribed to patients who are not being switched from tetrabenazine (a related VMAT2 inhibitor), the recommended starting dose of AUSTEDO is 12 mg per day (6 mg twice daily) for patients with tardive dyskinesia."
<https://www.austedo.com/tardive-dyskinesia/register>